Next Generation Sequencing Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Next Generation Sequencing Market

Next Generation Sequencing Market / NGS Market Size, Share & Trends by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) & Region - Global Forecast to 2027

FREE BROCHURE FREE SAMPLE REPORT
Report Code: BT 2697 Jan, 2023, by marketsandmarkets.com

Next Generation Sequencing Market Size, Share & Trends

The global market, for next generation sequencing is estimated to grow to USD 27.0 billion by 2027 from USD 13.0 billion in 2022 with a projected growth rate of 15.7% from 2022 to 2027. Emergence of new NGS technologies, reducing sequencing costs are expected to be drivers of market growth. Changes in reimbursement and regulatory guidelines are likely to benefit market players leading to an expansion of the market. Additionally, the use of NGS in medicine and the development of NGS systems present promising opportunities for market growth. Sequencing services are expected to emerge as an attractive market space in the next generation sequencing market; hot bets within this space include exome sequencing, targeted & custom sequencing, RNA sequencing, and De Novo sequencing. Some of the notable market players such as CD Genomics (US) and Eurofins Genomics (Germany) are actively engaged in introducing De Novo sequencing solutions.

Next Generation Sequencing Market Trends

Next Generation Sequencing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Next Generation Sequencing Market Dynamics

Driver: Advancements in NGS platforms

In last few years, prominent market players have introduced new technologies behind them provides an immediate competitive edge to players. Market players are now focusing on the increasing their R&D efforts in development of new product. PromethION (Oxford Nanopore Technologies), Ion Torrent Genexus Dx Integrated Sequencer (Thermo Fisher), iSeq 100 (Illumina), and Ion GeneStudio S5 System (Thermo Fisher) are the key revolutionary platforms in the market.

Restraint: End-user budget constraints in developing countries

Research and development, in institutions in developing countries heavily rely on financial support. Despite efforts from both private organizations to allocate funds for research globally many research institutions are encountering financial limitations when it comes to acquiring and utilizing sophisticated and costly equipment and technologies. Consequently, the establishment and growth of research facilities are being hindered in institutions in developing nations. This poses an obstacle to the integration of technologies like Next Generation Sequencing (NGS) in developing regions, across Africa and Asia.

Opportunity: Application of NGS in precision medicine and molecular diagnostics

Continuous developments in sequencing technologies and a better understanding of genomics have increased the efficiency of biomarkers in disease detection. Since precise diagnosis and personalized medicine increase survival rates as well as reduce the financial burden on national health insurance programs, governments across the globe are expected to make significant investments in genome sciences, which will ensure a positive future demand for NGS in such applications.

Consumables accounted for the largest share of next-generation sequencing market 

Next-generation sequencing market by product & services is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics. NGS consumables dominated the market in 2021. Various factors contributing to the growth of the segment are increasing demand for kits and reagents for sequencing procedures.

North America was the largest regional market for next-generation sequencing market in 2021.

The market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. Increasing number of genomics research projects, rising demand for new NGS platforms and growing use of NGS consumables are various factors projected to drive the growth of the market.

Next Generation Sequencing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Next Generation Sequencing: Market Ecosystem

The market ecosystem comprises raw material suppliers, NGS product providers service providers, and end users such as pharmaceutical & biotech companies, academic institutes, and reference laboratories. Raw material suppliers and service providers offer various supplies and services, such as instruments, consumables, assays, kits, and accessories for NGS. Key players in the market include Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China).

Scope of the Next Generation Sequencing Industry

Report Metric

Details

Market Revenue Size in 2022

$13 billion

Projected Revenue Size by 2027

$27 billion

Industry Growth Rate

Poised to Grow at a CAGR of 15.7%

Market Driver

Advancements in NGS platforms

Market Opportunity

Application of NGS in precision medicine and molecular diagnostics

The study categorizes the next generation sequencing market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • NGS Consumables
  • Sequencing Services
    • Exome & Targeted Resequencing and Custom Panels
    • RNA Sequencing
    • De Novo Sequencing
    • ChIP-Seq
    • Whole-genome Sequencing
    • Methyl Sequencing
    • Other Sequencing Services
  • Presequencing Products & Services
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Platforms
    • Illumina
      • Novaseq Systems
      • Nextseq Systems
      • Miseq Systems
      • Miniseq Systems
      • iSeq Systems
    • Thermo Fisher Scientific
      • ION PGM Systems
      • ION Proton Systems
      • ION Genestudio Systems
      • Ion Torrent Genexus Systems
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Other Platforms
  • Bioinformatics
    • Data Analysis Services
    • NGS Data Analysis Software & Workbenches
    • NGS Storage, Management, & Cloud Computing Solutions
  • Services for NGS Platforms
By Technology
  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies
By Application
  • Diagnostics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • Reproductive Health Diagnostics
    • Other Diagnostic Applications
  • Drug Discovery & Development
    • Pharmacogenomics
    • Other Drug Discovery and Development Applications
  • Agricultural & Animal Research
  • Other Applications
By End User
  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Reference Laboratories
  • Other End Users
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Middle East
    • Africa

Recent Developments of Next Generation Sequencing Industry

  • In October 2022 Illumina, from the United States and GenoScreen from France joined forces to increase the availability of testing for multidrug tuberculosis in countries heavily affected by the disease.
  • Additionally in the month Illumina collaborated with AstraZeneca, from the United Kingdom on a research partnership aimed at enhancing pipelines effectiveness through genetic variant identification.
  • Illumina (US) signed a strategic research cooperation with AstraZeneca (UK) in October 2022 in order to leverage the capacity to identify genetic variations causing human diseases so enhancing the efficiency of pharma pipelines.
  • Thermo Fisher Scientific (US) got FDA approval for the first NGS-based companion diagnostic to help in therapy selection for patients with RET Mutations/Fusions in thyroid malignancies in September 2022: the Oncomine Dx Target Test.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
 
4 PREMIUM INSIGHTS (Page No. - 55)
    4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 
    4.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 
    4.3 NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 2027 
    4.4 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Advancements in NGS platforms
                               5.2.1.1.1 PromethION 2 Solo
                               5.2.1.1.2 Ion Torrent Genexus Dx
                               5.2.1.1.3 iSeq 100 system
                               5.2.1.1.4 Ion GeneStudio S5
                    5.2.1.2 Declining cost of genome sequencing
                    5.2.1.3 Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests
                    5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
           5.2.2 RESTRAINTS
                    5.2.2.1 End-user budget constraints in developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Application of NGS in precision medicine and molecular diagnostics
                    5.2.3.2 Government and private support for large-scale sequencing
                    5.2.3.3 Advancements in NGS data analysis using big data
                    5.2.3.4 Development of portable sequencing technologies
                    5.2.3.5 Partnerships and collaborations for technological advancements in NGS
           5.2.4 CHALLENGES
                    5.2.4.1 Interpretation of complex data from NGS platforms
                    5.2.4.2 Ethical issues
                    5.2.4.3 Introduction of alternative technologies
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.4 PRICING ANALYSIS 
    5.5 TECHNOLOGY ANALYSIS 
    5.6 VALUE CHAIN ANALYSIS 
    5.7 ECOSYSTEM ANALYSIS 
    5.8 KEY CONFERENCES AND EVENTS IN 2023–2024 
    5.9 PORTER’S FIVE FORCES ANALYSIS 
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.1 KEY STAKEHOLDERS AND BUYING CRITERIA 
    5.11 PATENT ANALYSIS 
    5.12 REGULATORY ANALYSIS 
           5.12.1 NORTH AMERICA
                    5.12.1.1 US
                    5.12.1.2 Canada
           5.12.2 EUROPE
           5.12.3 ASIA PACIFIC
                    5.12.3.1 China
                    5.12.3.2 Japan
                    5.12.3.3 India
           5.12.4 LATIN AMERICA
           5.12.5 MIDDLE EAST
 
6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE (Page No. - 83)
    6.1 INTRODUCTION 
    6.2 NGS CONSUMABLES 
           6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES
    6.3 SEQUENCING SERVICES 
           6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
                    6.3.1.1 Development of technologically advanced NGS products and services to propel growth
           6.3.2 RNA SEQUENCING
                    6.3.2.1 Launch of RNA sequencing services to drive growth
           6.3.3 DE NOVO SEQUENCING
                    6.3.3.1 Rising awareness about advantages of De Novo sequencing to support growth
           6.3.4 CHIP SEQUENCING
                    6.3.4.1 Increasing demand for ChIP sequencing services to propel growth
           6.3.5 WHOLE-GENOME SEQUENCING
                    6.3.5.1 Reducing whole-genome sequencing costs to propel growth
           6.3.6 METHYL SEQUENCING
                    6.3.6.1 Rising importance of DNA methylation in study of cancer to drive growth
           6.3.7 OTHER SEQUENCING SERVICES
    6.4 PRE-SEQUENCING PRODUCTS & SERVICES 
           6.4.1 LIBRARY PREPARATION AND TARGET ENRICHMENT
                    6.4.1.1 Development of advanced library preparation solutions to boost growth
           6.4.2 QUALITY CONTROL
                    6.4.2.1 Importance of quality control in NGS workflow to drive growth
    6.5 NGS PLATFORMS 
           6.5.1 ILLUMINA
                    6.5.1.1 NovaSeq systems
                    6.5.1.2 NextSeq systems
                    6.5.1.3 MiSeq systems
                    6.5.1.4 iSeq 100 systems
                    6.5.1.5 MiniSeq systems
           6.5.2 THERMO FISHER SCIENTIFIC
           6.5.3 OXFORD NANOPORE TECHNOLOGIES
           6.5.4 PACIFIC BIOSCIENCES
           6.5.5 OTHER NGS PLATFORMS
    6.6 BIOINFORMATICS 
           6.6.1 NGS DATA ANALYSIS SERVICES
                    6.6.1.1 Rising awareness about NGS data analysis services to boost growth
           6.6.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
                    6.6.2.1 Development of advanced bioinformatics solutions to drive growth
           6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
                    6.6.3.1 Launch of cloud-based solutions to drive market
    6.7 SERVICES FOR NGS PLATFORMS 
           6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH
 
7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY (Page No. - 144)
    7.1 INTRODUCTION 
    7.2 SEQUENCING BY SYNTHESIS 
           7.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD
    7.3 ION SEMICONDUCTOR SEQUENCING 
           7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING
    7.4 NANOPORE SEQUENCING 
           7.4.1 NANOPORE SEQUENCING—ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
    7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 
           7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS
    7.6 OTHER SEQUENCING TECHNOLOGIES 
 
8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION (Page No. - 161)
    8.1 INTRODUCTION 
    8.2 DIAGNOSTICS 
           8.2.1 CANCER DIAGNOSTICS
                    8.2.1.1 High adoption of NGS in cancer diagnostics to propel growth
           8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
                    8.2.2.1 Applications in infectious disease surveillance and launch of new tests to drive growth
           8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
                    8.2.3.1 Extensive use of NGS in NIPT to boost growth
           8.2.4 OTHER DIAGNOSTIC APPLICATIONS
    8.3 DRUG DISCOVERY AND DEVELOPMENT 
           8.3.1 PHARMACOGENOMICS
                    8.3.1.1 Advent of NGS to understand genomic variants in humans to drive growth
           8.3.2 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS
    8.4 AGRICULTURAL AND ANIMAL RESEARCH 
           8.4.1 NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH
    8.5 OTHER APPLICATIONS 
 
9 NEXT-GENERATION SEQUENCING MARKET, BY END USER (Page No. - 194)
    9.1 INTRODUCTION 
    9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS 
           9.2.1 ACADEMIC AND RESEARCH INSTITUTES TO ACCOUNT FOR LARGEST MARKET SHARE
    9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
           9.3.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH
    9.4 HOSPITALS AND CLINICS 
           9.4.1 EXPANDING USE OF NGS IN HOSPITALS AND CLINICS TO BOOST GROWTH
    9.5 REFERENCE LABORATORIES 
           9.5.1 INCREASING AVAILABILITY OF TESTING SOLUTIONS AND HIGH ADOPTION OF NGS IN REFERENCE LABORATORIES TO DRIVE GROWTH
    9.6 OTHER END USERS 
 
10 NEXT-GENERATION SEQUENCING MARKET, BY REGION (Page No. - 210)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 US
                        10.2.1.1 Growing R&D activities in US to drive market growth
             10.2.2 CANADA
                        10.2.2.1 Increasing government initiatives in genomics research to boost adoption of NGS
             10.2.3 NORTH AMERICA: RECESSION IMPACT
     10.3 EUROPE 
             10.3.1 GERMANY
                        10.3.1.1 Germany dominates European next-generation sequencing market
             10.3.2 UK
                        10.3.2.1 Strategic initiatives and funding for genomics research to support adoption of NGS
             10.3.3 FRANCE
                        10.3.3.1 Government initiatives for genomics research to drive growth
             10.3.4 ITALY
                        10.3.4.1 Favorable funding scenario to drive adoption of next-generation sequencing
             10.3.5 SPAIN
                        10.3.5.1 Focus on expanding genomic research to support growth
             10.3.6 NETHERLANDS
                        10.3.6.1 Focus on implementation of NGS to boost growth
             10.3.7 REST OF EUROPE
             10.3.8 EUROPE: RECESSION IMPACT
     10.4 ASIA PACIFIC 
             10.4.1 CHINA
                        10.4.1.1 China to register highest growth in Asia Pacific market
             10.4.2 JAPAN
                        10.4.2.1 Rising number of collaborations for NGS to boost market growth
             10.4.3 INDIA
                        10.4.3.1 Government initiatives for genomics to support market growth
             10.4.4 AUSTRALIA
                        10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
             10.4.5 REST OF ASIA PACIFIC
             10.4.6 ASIA PACIFIC: RECESSION IMPACT
     10.5 LATIN AMERICA 
             10.5.1 BRAZIL
                        10.5.1.1 Rising focus on clinical genomics to drive demand for NGS
             10.5.2 MEXICO
                        10.5.2.1 Biotechnology infrastructure development to support market growth
             10.5.3 REST OF LATIN AMERICA
             10.5.4 LATIN AMERICA: RECESSION IMPACT
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 MIDDLE EAST
                        10.6.1.1 Expansion by prominent players and launch of genomic initiatives to support growth
             10.6.2 AFRICA
                        10.6.2.1 Collaborations among market players and government bodies to boost growth
             10.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 322)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
     11.3 REVENUE ANALYSIS 
     11.4 MARKET SHARE ANALYSIS 
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
             11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
             11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
     11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
     11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 
     11.9 COMPETITIVE SCENARIO AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 OTHER DEVELOPMENTS
 
12 COMPANY PROFILES (Page No. - 338)
     12.1 KEY PLAYERS 
             12.1.1 ILLUMINA, INC.
                        12.1.1.1 Business overview
                        12.1.1.2 Products & services offered
                        12.1.1.3 Recent developments
                        12.1.1.4 MnM view
                                     12.1.1.4.1 Key strengths
                                     12.1.1.4.2 Strategic choices made
                                     12.1.1.4.3 Weaknesses and competitive threats
             12.1.2 THERMO FISHER SCIENTIFIC, INC.
                        12.1.2.1 Business overview
                        12.1.2.2 Products & services offered
                        12.1.2.3 Recent developments
                        12.1.2.4 MnM view
                                     12.1.2.4.1 Key strengths
                                     12.1.2.4.2 Strategic choices made
                                     12.1.2.4.3 Weaknesses and competitive threats
             12.1.3 PERKINELMER
                        12.1.3.1 Business overview
                        12.1.3.2 Products & services offered
                        12.1.3.3 Recent developments
                        12.1.3.4 MnM view
                                     12.1.3.4.1 Key strengths
                                     12.1.3.4.2 Strategic choices made
                                     12.1.3.4.3 Weaknesses and competitive threats
             12.1.4 AGILENT TECHNOLOGIES, INC.
                        12.1.4.1 Business overview
                        12.1.4.2 Products & services offered
                        12.1.4.3 Recent developments
             12.1.5 PACIFIC BIOSCIENCES
                        12.1.5.1 Business overview
                        12.1.5.2 Products & services offered
                        12.1.5.3 Recent developments
             12.1.6 OXFORD NANOPORE TECHNOLOGIES
                        12.1.6.1 Business overview
                        12.1.6.2 Products offered
                        12.1.6.3 Recent developments
             12.1.7 BGI GROUP
                        12.1.7.1 Business overview
                        12.1.7.2 Products & services offered
                        12.1.7.3 Recent developments
             12.1.8 QIAGEN
                        12.1.8.1 Business overview
                        12.1.8.2 Products & services offered
                        12.1.8.3 Recent developments
             12.1.9 F. HOFFMANN-LA ROCHE AG
                        12.1.9.1 Business overview
                        12.1.9.2 Products offered
                        12.1.9.3 Recent developments
             12.1.10 EUROFINS SCIENTIFIC
                        12.1.10.1 Business overview
                        12.1.10.2 Products & services offered
                        12.1.10.3 Recent developments
             12.1.11 BROOKS AUTOMATION, INC.
                        12.1.11.1 Business overview
                        12.1.11.2 Services offered
                        12.1.11.3 Recent developments
             12.1.12 PSOMAGEN
                        12.1.12.1 Business overview
                        12.1.12.2 Services offered
                        12.1.12.3 Recent developments
             12.1.13 10X GENOMICS
                        12.1.13.1 Business overview
                        12.1.13.2 Products offered
                        12.1.13.3 Recent developments
             12.1.14 TECAN TRADING GROUP
                        12.1.14.1 Business overview
                        12.1.14.2 Products offered
             12.1.15 ZYMO RESEARCH
                        12.1.15.1 Business overview
                        12.1.15.2 Products & services offered
                        12.1.15.3 Recent developments
             12.1.16 TAKARA BIO
                        12.1.16.1 Business overview
                        12.1.16.2 Products offered
             12.1.17 PROMEGA CORPORATION
                        12.1.17.1 Business overview
                        12.1.17.2 Products offered
                        12.1.17.3 Recent developments
             12.1.18 CD GENOMICS
                        12.1.18.1 Business overview
                        12.1.18.2 Products & services offered
                        12.1.18.3 Recent developments
             12.1.19 NEW ENGLAND BIOLABS
                        12.1.19.1 Business overview
                        12.1.19.2 Products offered
                        12.1.19.3 Recent developments
             12.1.20 NOVOGENE CORPORATION INC.
                        12.1.20.1 Business overview
                        12.1.20.2 Services offered
                        12.1.20.3 Recent developments
     12.2 OTHER COMPANIES 
             12.2.1 HAMILTON COMPANY
             12.2.2 MEDGENOME
             12.2.3 BECTON, DICKINSON AND COMPANY
             12.2.4 COSMOSID, INC.
             12.2.5 GENOTYPIC TECHNOLOGY
             12.2.6 LGC LIMITED
 
13 APPENDIX (Page No. - 447)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (517 TABLES)
 
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
TABLE 4 NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 5 CANCER INCIDENCE, 2020 VS. 2040
TABLE 6 GLOBAL SEQUENCING INITIATIVES
TABLE 7 PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018–DECEMBER 2022
TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
TABLE 9 SANGER SEQUENCING VS. NGS
TABLE 10 SUPPLY CHAIN ECOSYSTEM
TABLE 11 NEXT-GENERATION SEQUENCING MARKET: LIST OF CONFERENCES AND EVENTS
TABLE 12 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 16 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 17 NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 23 SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 24 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 25 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 30 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 33 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 34 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 36 RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 42 DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 48 CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 54 WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 58 LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 64 LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
TABLE 70 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 72 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 77 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 79 LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 82 ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 85 QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 91 NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 93 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 94 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 98 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 100 NOVASEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 101 NEXTSEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 102 MISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 103 ISEQ 100 SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 104 MINISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 105 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 107 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 108 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 109 OTHER NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 110 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 111 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 112 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 114 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 115 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 117 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 118 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 119 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 120 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 121 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 123 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 124 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 125 EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 126 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 127 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 128 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 129 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 130 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 133 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 135 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 136 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 137 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 138 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 139 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 141 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
TABLE 142 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 143 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 144 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 145 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 147 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 149 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 150 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 151 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 152 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 153 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 155 NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 156 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 157 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 158 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 159 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 161 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 162 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 163 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 164 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 165 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 167 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 168 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 169 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 170 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 173 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 174 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 176 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 177 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 178 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 179 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 181 NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 187 NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 188 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 189 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 190 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 191 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 193 NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 194 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 195 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 196 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 197 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 199 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 200 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 201 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 202 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 203 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 205 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
TABLE 207 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 208 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 209 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 210 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
TABLE 212 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 213 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 214 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 215 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 216 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 218 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 219 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 220 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 221 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 222 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 224 NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
TABLE 225 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 226 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 227 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 228 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 229 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
TABLE 230 NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 231 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 232 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 233 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 234 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 235 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 236 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 237 NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 238 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 239 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 240 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 241 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 242 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 243 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 244 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 245 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 246 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 247 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 249 NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 250 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 251 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 253 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 254 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION)
TABLE 255 NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 256 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 257 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 258 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 259 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 260 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 261 NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 262 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 263 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 264 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 265 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 266 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 267 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 268 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 269 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 270 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 272 NORTH AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 273 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 274 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 275 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 278 US: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 279 US: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 280 US: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 281 US: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 US: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 283 US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 284 US: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 285 US: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 286 US: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 287 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 288 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 CANADA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 CANADA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 292 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 293 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 294 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 295 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 296 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 297 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 298 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 302 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 303 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 304 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 305 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 306 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 307 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 GERMANY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 GERMANY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 311 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 312 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 314 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 315 UK: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 316 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 317 UK: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 318 UK: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 UK: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 320 UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 321 UK: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 UK: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 323 UK: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 324 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 325 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 326 FRANCE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 327 FRANCE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 328 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 329 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 330 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 331 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 332 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 333 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 334 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 335 ITALY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 336 ITALY: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 337 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 338 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 339 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 340 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 341 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 342 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 343 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 344 SPAIN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 345 SPAIN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 346 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 347 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 348 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 349 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 350 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 351 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 352 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 353 NETHERLANDS: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 354 NETHERLANDS: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 355 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 356 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 357 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 358 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 359 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 360 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 361 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 362 REST OF EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 363 REST OF EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 364 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 365 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 366 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 367 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 368 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 369 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 370 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 371 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 372 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 373 ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 374 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 375 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 376 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 377 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 378 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 379 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 380 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 381 CHINA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 382 CHINA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 383 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 384 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 385 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 386 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 387 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 388 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 389 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 390 JAPAN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 391 JAPAN: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 392 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 393 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 394 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 395 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 396 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 397 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 398 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 399 INDIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 400 INDIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 401 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 402 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 403 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 404 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 405 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 406 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 407 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 408 AUSTRALIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 409 AUSTRALIA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 410 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 411 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 412 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 413 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 414 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 415 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 416 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 417 REST OF ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 418 REST OF ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 419 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 420 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 421 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 422 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 423 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 424 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 425 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 426 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 427 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 428 LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 429 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 430 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 431 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 432 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 433 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 434 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 435 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 436 BRAZIL: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 437 BRAZIL: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 438 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 439 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 440 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 441 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 442 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 443 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 444 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 445 MEXICO: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 446 MEXICO: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 447 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 448 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 449 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 450 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 451 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 452 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 453 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 454 REST OF LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 455 REST OF LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 456 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 457 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 458 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 459 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 460 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 461 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 462 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 463 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 464 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 465 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 466 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 467 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 468 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 469 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 470 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 471 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 472 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 473 MIDDLE EAST: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 474 MIDDLE EAST: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 475 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 476 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 477 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 478 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 479 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 480 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 481 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 482 AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 483 AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 484 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 485 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 486 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 487 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)
TABLE 488 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 489 NEXT-GENERATION SEQUENCING MARKET: DEGREE OF COMPETITION
TABLE 490 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 491 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 492 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 493 NEXT-GENERATION SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 494 NEXT-GENERATION SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
TABLE 495 NEXT-GENERATION SEQUENCING MARKET: KEY PRODUCT LAUNCHES, JANUARY 2019–DECEMBER 2022
TABLE 496 NEXT-GENERATION SEQUENCING MARKET: KEY DEALS, JANUARY 2019–DECEMBER 2022
TABLE 497 NEXT-GENERATION SEQUENCING MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2019–DECEMBER 2022
TABLE 498 ILLUMINA, INC.: BUSINESS OVERVIEW
TABLE 499 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
TABLE 500 PERKINELMER: BUSINESS OVERVIEW
TABLE 501 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
TABLE 502 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW
TABLE 503 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW
TABLE 504 BGI GROUP: BUSINESS OVERVIEW
TABLE 505 QIAGEN: BUSINESS OVERVIEW
TABLE 506 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
TABLE 507 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
TABLE 508 BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW
TABLE 509 PSOMAGEN: BUSINESS OVERVIEW
TABLE 510 10X GENOMICS: BUSINESS OVERVIEW
TABLE 511 TECAN TRADING GROUP: BUSINESS OVERVIEW
TABLE 512 ZYMO RESEARCH: BUSINESS OVERVIEW
TABLE 513 TAKARA BIO: BUSINESS OVERVIEW
TABLE 514 PROMEGA CORPORATION: BUSINESS OVERVIEW
TABLE 515 CD GENOMICS: BUSINESS OVERVIEW
TABLE 516 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
TABLE 517 NOVOGENE CORPORATION INC.: BUSINESS OVERVIEW
 
 
LIST OF FIGURES (48 FIGURES)
 
FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 NEXT-GENERATION SEQUENCING MARKET: PRIMARY RESPONDENTS
FIGURE 4 NEXT-GENERATION SEQUENCING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2022–2027
FIGURE 8 NEXT-GENERATION SEQUENCING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEXT-GENERATION SEQUENCING MARKET
FIGURE 15 ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH
FIGURE 16 NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
FIGURE 17 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 19 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2021
FIGURE 21 NUMBER OF NEW CANCER CASES WORLDWIDE, 2020
FIGURE 22 DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–2019
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
FIGURE 24 VALUE CHAIN ANALYSIS OF NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
FIGURE 25 VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES
FIGURE 26 ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES
FIGURE 28 BUYING CRITERIA FOR NGS PRODUCTS
FIGURE 29 PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012–DECEMBER 2022
FIGURE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
FIGURE 31 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
FIGURE 32 NEXT-GENERATION SEQUENCING MARKET: STRATEGIES ADOPTED
FIGURE 33 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
FIGURE 34 NEXT-GENERATION SEQUENCING MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
FIGURE 35 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021
FIGURE 36 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
FIGURE 37 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
FIGURE 39 PERKINELMER: COMPANY SNAPSHOT (2021)
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
FIGURE 41 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2021)
FIGURE 42 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2021)
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021)
FIGURE 44 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
FIGURE 46 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2021)
FIGURE 47 TECAN GROUP: COMPANY SNAPSHOT (2021)
FIGURE 48 TAKARA BIO: COMPANY SNAPSHOT (2021)

This study involved four major activities in estimating the current size of the next generation sequencing (NGS) market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the next-generation sequencing market. The secondary sources used for this study include Press Releases, Annual Reports, White Papers, Certified Publications, Articles form authorized authors, Directories and Databases, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Next Generation Sequencing Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the next generation sequencing (NGS) market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the NGS and related products business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global next generation sequencing (NGS) market based on the product, application, technology, end user, and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities).
  • To strategically analyse micromarkets with respect to individual growth trends, future prospects, and contributions to the overall next generation sequencing (NGS) market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To strategically profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
  • To track and analyse competitive developments such as product launches, expansions, acquisitions, agreements, collaborations, and partnerships in the next generation sequencing (NGS) market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2697
Published ON
Jan, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Request New Version Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next Generation Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback